Cognizant's AI alliances, especially with Devin, expose a deep structural weakness in their core IT services model.
OPKO Health is at J.P. Morgan, but the real story isn't the conference; it's the silent battle for solvency in the volatile biotech sector.
Dajialai's bizarre acquisition of Newberry Specialty Bakers isn't about bread; it's a desperate play for US market perception and obscure OTC trading access.
Forget the hype around Gemini Deep Research; this is Google's desperate attempt to regain dominance in the AI arms race. We analyze the hidden cost.
Microchip Technology's massive stock jump isn't just about outlook; it's a calculated move signaling deeper industrial consolidation in the volatile semiconductor space.